VanEck Pharmaceutical ETF
PPH
#1326
ETF rank
C$1.56 B
Marketcap
๐Ÿ‡บ๐Ÿ‡ธ US
Market
C$161.52
Share price
1.77%
Change (1 day)
24.82%
Change (1 year)

Expense ratio and fees for VanEck Pharmaceutical ETF (PPH)

Expense Ratio

Expense Ratio as of May 2025: 0.36%

Gross Expense Ratio

Gross Expense Ratio as of October 2026: 0.36%

Net Expense Ratio

Net Expense Ratio as of October 2026: 0.36%